We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

3 hedge funds and large institutions have $2.04M invested in Albireo Pharma Inc in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 92 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% less funds holding

Funds holding: 96 → 3 (-93)

99% less capital invested

Capital invested by funds: $396M → $2.04M (-$394M)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 92

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
3
Holders Change
-93
Holders Change %
-96.88%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
92
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$42.3M
2
PA
Perceptive Advisors
New York
-$38M
3
DTC
Deep Track Capital
Connecticut
-$36.8M
4
CC
Chicago Capital
Illinois
-$29.4M
5
BlackRock
BlackRock
New York
-$29.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
76
US Bancorp
Minnesota
– -$57.7K -2,669 Closed
Royal Bank of Canada
77
Royal Bank of Canada
Ontario, Canada
– -$51K -2,397 Closed
Citadel Advisors
78
Citadel Advisors
Florida
– -$46.9K -2,169 Closed
QCG
79
Quadrant Capital Group
Ohio
– -$39.9K -1,845 Closed
AIP
80
Ameritas Investment Partners
Nebraska
– -$62.2K -1,419 Closed
MLICM
81
Metropolitan Life Insurance Company (MetLife)
New York
– -$23.5K -1,087 Closed
Canada Life
82
Canada Life
Manitoba, Canada
– -$22K -1,031 Closed
TRCT
83
Tower Research Capital (TRC)
New York
– -$22K -1,004 Closed
Allspring Global Investments
84
Allspring Global Investments
North Carolina
– -$21.6K -1,000 Closed
QT
85
Quantbot Technologies
New York
– -$21.6K -1,000 Closed
Osaic Holdings
86
Osaic Holdings
Arizona
– -$40.8K -972 Closed
Group One Trading
87
Group One Trading
Illinois
– -$16.7K -773 Closed
Citigroup
88
Citigroup
New York
– -$12.2K -563 Closed
KTC
89
Kistler-Tiffany Companies
Pennsylvania
– -$10.8K -500 Closed
LC
90
Lindbrook Capital
California
– -$8.99K -416 Closed
S
91
SignatureFD
Georgia
– -$8.34K -386 Closed
Carson Wealth (CWM LLC)
92
Carson Wealth (CWM LLC)
Nebraska
– -$5K -220 Closed
National Bank of Canada
93
National Bank of Canada
Quebec, Canada
– -$4.12K -191 Closed
AF
94
Allworth Financial
California
– -$1.32K -61 Closed
Nisa Investment Advisors
95
Nisa Investment Advisors
Missouri
– -$1K -24 Closed
1 2 3
4

ALBO Hedge Fund Activity: Q1 2023 in Review

3 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q1 2023, worth a combined $2.04M — down 99% from $396M a quarter earlier.

Sellers outnumbered buyers: 92 funds closed out of ALBO and 0 opened new positions — a net loss of 92 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was Federated Hermes, exiting entirely with an estimated $42.3M sold.

  • 3 institutional investors held Albireo Pharma Inc (ALBO) as of Q1 2023, down from 96 in Q4 2022.
  • Funds reported $2.04M of Albireo Pharma Inc stock for Q1 2023, down 99% quarter-over-quarter.
  • 0 funds opened new Albireo Pharma Inc positions in Q1 2023 and 92 closed out, a net change of -92 holders.
  • The largest Albireo Pharma Inc seller in Q1 2023 was Federated Hermes, an estimated $42.3M sold.

Based on aggregated 13F filings for Q1 2023.